This Auditing for GMP course is specifically designed to address the challenges of GMP auditing for the pharmaceutical industry and present the basic competencies required to effe ...
The "Best Practices for Supplier Qualification in Life Science Training Course (May 6th - May 7th, 2026)" has been added to ResearchAndMarkets.com's offering. Conduct thorough supplier qualifications ...
Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...
Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...
The "Auditing and Qualifying Suppliers and Vendors: An Effective Risk-based Approach (Mar 3rd - Mar 5th, 2026)" training has ...
Dear reader, the pharmaceutical industry plays a crucial role in protecting human health, which necessitates stringent ...
The health ministry is unlikely to extend the Schedule M deadline for MSME pharma firms beyond December 31, 2025, as it ...
New GNC Pro Performance Creatine + HMB pairs 5g of creatine monohydrate with 3 g of myHMB (R) in an unflavored powder designed to mix easily into shakes or pre-workouts. The combination is crafted for ...
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
In order to usher in domestic & global regulatory compliance in pharma sector under the current revised Schedule M regime in India, cGxP Lifeline hosted its first Annual Conference 2025 in Mumbai ...
CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.